Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77.8M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
+475K
-
Total reported value, excl. options
-
$74.8M
-
Value change
-
+$2.02M
-
Put/Call ratio
-
66.04
-
Number of buys
-
17
-
Number of sells
-
-13
-
Price
-
$4.74
Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q1 2023
44 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q1 2023.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 77.8M outstanding shares and own 20.27% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.5M shares), RA CAPITAL MANAGEMENT, L.P. (3.43M shares), Bain Capital Life Sciences Investors, LLC (3.13M shares), Camber Capital Management LP (1.42M shares), Laurion Capital Management LP (928K shares), Artal Group S.A. (909K shares), Alyeska Investment Group, L.P. (647K shares), Finepoint Capital LP (489K shares), CAAS CAPITAL MANAGEMENT LP (245K shares), and PURA VIDA INVESTMENTS, LLC (225K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.